iCAD Announces CEO Transition
06 déc. 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Dec. 06, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that its...
iCAD Announces Compelling New and Real-World Data Demonstrating the Value of ProFound AI to be Presented at RSNA 2021
29 nov. 2021 08h00 HE
|
iCAD, Inc.
World’s first FDA cleared AI breast cancer detection software to be highlighted in three scientific presentations at largest radiological meeting in the world iCAD’s innovative breast health...
iCAD to Participate in the 12th Annual Craig-Hallum Alpha Select Conference
11 nov. 2021 16h05 HE
|
iCAD, Inc.
NASHUA, N.H., Nov. 11, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD to Host 2nd Annual Virtual Investor Webinar on Company’s Innovative Solutions for Cancer Detection and Treatment
11 nov. 2021 08h00 HE
|
iCAD, Inc.
Leading clinical and administrative experts to discuss how leveraging iCAD’s Breast Health Solutions and the Xoft System can enhance clinical efficiency and improve outcomes for patients Webinar...
iCAD Reports Financial Results for the Quarter Ended September 30, 2021
09 nov. 2021 16h05 HE
|
iCAD, Inc.
- Third Quarter Revenues of $9.4 Million Represented 20% Sequential Quarter Growth over the Second Quarter of 2021, Driven by 26% Growth in Detection Revenue and 10% Growth in Therapy Revenue - ...
iCAD to Report Third Quarter 2021 Financial Results on Tuesday, November 9
26 oct. 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Oct. 26, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD Unveils Next Generation Technologies at Journées Francophones de Radiologie (October 8-11, Paris, France)
07 oct. 2021 08h00 HE
|
iCAD, Inc.
Leading-edge AI solution for 2D mammography enhances cancer detection performance for clinicians, with improved sensitivity, specificity, and processing times over previous versions Latest...
iCAD Launches Revolutionary Short-term Personalized Risk Assessment Solution for 3D Mammography
29 sept. 2021 08h00 HE
|
iCAD, Inc.
Latest generation of ProFound AI Risk offers greater accuracy and ethnically inclusive precision screening Technology provides critical, risk-adaptive solutions for clinicians facing complex...
iCAD to Host Educational Roundtable to Help Clinicians and Facilities Recover from COVID-19 Impact
09 sept. 2021 14h46 HE
|
iCAD, Inc.
NASHUA, N.H., Sept. 09, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it...
iCAD’s Xoft Brain IORT Demonstrates Significant Improvement in Overall Survival in Recurrent Glioblastoma According to Comparative Study
31 août 2021 08h00 HE
|
iCAD, Inc.
NASHUA, N.H., Aug. 31, 2021 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that...